Literature DB >> 9700485

Connexin32-null mice develop demyelinating peripheral neuropathy.

S S Scherer1, Y T Xu, E Nelles, K Fischbeck, K Willecke, L J Bone.   

Abstract

Mutations in the gene encoding the gap junction protein connexin32 (Cx32) cause X-linked Charcot-Marie-Tooth disease (CMTX), a common form of inherited demyelinating peripheral neuropathy. To learn more about the pathogenesis of CMTX, we examined the PNS and CNS of cx32-null mice (cx32-/Y males and cx32-/-females) by light and electron microscopy. These mice develop a progressive demyelinating peripheral neuropathy beginning by 3 months of age, and at all ages, motor fibers are more affected than sensory fibers. Like other genes of the X chromosome, the cx32 gene appears to be randomly inactivated, since only some myelinating Schwann cells express Cx32 in heterozygous cx32 +/- females. Heterozygous cx32 +/- females have fewer demyelinated and remyelinated axons than age-matched homozygous cx32-/- females and cx32-/Y males. Although oligodendrocytes also express Cx32, no abnormalities in CNS myelin were found. These findings indicate that a null cx32 allele in myelinating Schwann cells is sufficient to cause an inherited demyelinating neuropathy, so that Cx32 has an essential role in myelinating Schwann cells both in mice and in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700485     DOI: 10.1002/(sici)1098-1136(199809)24:1<8::aid-glia2>3.0.co;2-3

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  79 in total

1.  GJB1/Connexin 32 whole gene deletions in patients with X-linked Charcot-Marie-Tooth disease.

Authors:  Claudia Gonzaga-Jauregui; Feng Zhang; Charles F Towne; Sat Dev Batish; James R Lupski
Journal:  Neurogenetics       Date:  2010-06-09       Impact factor: 2.660

2.  The role of gap junctions in Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

3.  Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy.

Authors:  Natalie Vavlitou; Irene Sargiannidou; Kyriaki Markoullis; Kyriacos Kyriacou; Steven S Scherer; Kleopas A Kleopa
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

4.  Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice.

Authors:  Nellie Byun; Eric Delpire
Journal:  Neurobiol Dis       Date:  2007-06-23       Impact factor: 5.996

Review 5.  Gap junctions couple astrocytes and oligodendrocytes.

Authors:  Jennifer L Orthmann-Murphy; Charles K Abrams; Steven S Scherer
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

6.  Functional heterotypic interactions between astrocyte and oligodendrocyte connexins.

Authors:  Laura M Magnotti; Daniel A Goodenough; David L Paul
Journal:  Glia       Date:  2011-01       Impact factor: 7.452

7.  Regulation of Connexin32 by ephrin receptors and T-cell protein-tyrosine phosphatase.

Authors:  Andrew J Trease; Hanjun Li; Gaelle Spagnol; Li Zheng; Kelly L Stauch; Paul L Sorgen
Journal:  J Biol Chem       Date:  2018-11-06       Impact factor: 5.157

Review 8.  Molecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system.

Authors:  J E Rash
Journal:  Neuroscience       Date:  2009-10-20       Impact factor: 3.590

Review 9.  Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models.

Authors:  Emilie Hoang Dinh; Shoeb Ahmad; Qing Chang; Wenxue Tang; Benjamin Stong; Xi Lin
Journal:  Brain Res       Date:  2009-02-20       Impact factor: 3.252

10.  Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kip1-deficient mice.

Authors:  Timothy J King; Paul D Lampe
Journal:  Cell Commun Adhes       Date:  2005 Jul-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.